Optimizing ribavirin dose is critical for sustained viral response in patients with thalassemia major treated for chronic hepatitis C

Paul J Clark, Rosanna Santoro, Valeria Piazzolla, Leonardo Mottola, D Bacca, N Dello Iacono, Salvatore Grimaldi, Antonella Quarta, Thomas J Urban, Susanna Naggie, Keyur Patel, Alexander J Thompson, Andrew J Muir, Alessandra Mangia